Navigation Links
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
Date:8/3/2009

tart thinking about suicide or wanting to hurt yourself.

In a study of people taking INVEGA((R)) SUSTENNA(TM), common side effects in the treatment of schizophrenia were reactions at the injection site, sleepiness, dizziness, feeling of inner restlessness, and abnormal muscle movements, including tremor (shaking), shuffling, uncontrolled involuntary movements, and abnormal movements of the eyes.

This is not a complete list of all possible side effects. Ask your doctor or treatment team if you have any questions or want more information.

If you have any questions about INVEGA((R)) SUSTENNA(TM) or your therapy, talk with your doctor.

About INVEGA((R)) SUSTENNA(TM)

INVEGA(R) SUSTENNA(TM) is approved for the acute and maintenance treatment of schizophrenia. It is the first once-monthly, long-acting, injectable atypical antipsychotic approved for this use in the U.S. INVEGA(R) SUSTENNA(TM) is available in milligrams (mg) of paliperidone palmitate in dose strengths of 39 mg, 78 mg, 117 mg, 156 mg and 234 mg. Please be aware that clinical trial data presented at medical meetings were often reported as milligram equivalents (mg eq.) to paliperidone. Each dose of paliperidone palmitate is equivalent to a specific dose of paliperidone (39 mg, 78 mg, 117 mg, 156 mg and 234 mg of paliperidone palmitate is equivalent to 25 mg, 50 mg, 75 mg, 100 mg and 150 mg of paliperidone, respectively).

The pre-filled syringes require no reconstitution or refrigeration. Patients initiate treatment with two injections administered in the deltoid muscle one week apart (Day 1 at 234 mg and Day 8 at 156 mg), followed by injections every month thereafter administered in either the deltoid or gluteal muscle. INVEGA(R) SUSTENNA(TM) was developed utilizing Elan Drug Technologies' proprietary NanoCrystal((R)) Technology. Using this technology increases the rate of dissolut
'/>"/>

SOURCE Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skins Natural Moisture
2. Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology
3. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
4. Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
5. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
6. Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
7. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
8. Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
9. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
10. Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
11. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015  EndoChoice Holdings, Inc. (NYSE:  GI) announced ... financial results on Thursday, August 6, 2015 before the ... conference call on Thursday, August 6, 2015 at 9:00 ... are (866) 807-9684 for domestic callers and (412) 317-5415 ... call will be available on the investor relations section ...
(Date:7/6/2015)... , July 6, 2015 Flower ... fixation concept the FlowerCube™, announced today that it ... the opportunity for significant expansion of the innovative ... The approval encompasses Flower Orthopedics, entire product ... for upper and lower extremities. Consisting of more ...
(Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/bkw8kk/pharmaceutical ) has ... in North America 2015-2019" report to their offering. ... North America to grow at a CAGR ... International regulations regarding safe drug delivery are enforced by ... adoption of sustainable packaging. Various raw materials such as ...
Breaking Medicine Technology:EndoChoice to Report Second Quarter 2015 Financial Results on August 6, 2015 2Flower Orthopedics cleared to enter the European Union 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3
... The Chinese Biopharmaceutical Association-USA (CBA) successfully held its 16 ... US.   With the theme of ... the conference drew nearly 500 attendees with ... exhibited at the conference, including Chinese leading biotech parks, ...
... The Council on Competitiveness, in partnership with the ... case study today highlighting the potential for high performance ... facing the health care industry. The report, " ... the Delivery of ,Smarter, Health Care ," studies ...
Cached Medicine Technology:Chinese Biopharmaceutical Association Successfully Holds 16th Annual Conference 2Chinese Biopharmaceutical Association Successfully Holds 16th Annual Conference 3Council on Competitiveness Showcases Power of High Performance Computing in Case Study with GNS Healthcare 2
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... program modernization, today announced they have been selected by the Department of Vermont ... services for its Medicaid Management Information System (MMIS) and Integrated Contact Center System ...
(Date:7/6/2015)... ... 06, 2015 , ... For over twenty years, Doctors on Liens ... Throughout the company’s history the goal has been to be a comprehensive network of ... And while Doctors on Liens has certainly achieved that goal, the addition of ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... the pre-clinical stages of drug discovery. iPSCs are generated from adult cells, such ... into any cell type in the human body. , iPSC-derived cardiomyocytes ...
(Date:7/6/2015)... Laguna Woods, CA (PRWEB) , ... July 06, ... ... first Water Revival System that eliminates 100% of all acids, chemicals and impurities; ... not suggested for drinking water because it contains harmful contaminants.  These harmful contaminants ...
(Date:7/6/2015)... ... , ... University of Pittsburgh Cancer Institute (UPCI) scientists recently led ... newly available tests that better incorporate personalized medicine into diagnosing the condition. , ... is published in the July issue of the scientific journal Thyroid . ...
Breaking Medicine News(10 mins):Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4Health News:Pristine Water Filters.com Offers The 1st Water Revival System That Re-Mineralizes Drinking Water and Eliminates All Impurities and Chemicals 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5
... molecules convey genetic instructions from nuclei to fulfill different ... proteins a cell makes when and where appears to ... say researchers at the Stanford University School of Medicine. ... that certain proteins guide molecules carrying genetic instructions from ...
... Quarter Sales, SALT LAKE CITY, Oct. 28 Sonic ... digital hearing aids,today announced results for the third quarter ended ... Achieved record third quarter sales from continuing operations of ... growth compared to third quarter 2007. ...
... 28 /PRNewswire-FirstCall/,-- ProAssurance Corporation (NYSE: PRA ) ... of ProAssurance through an all cash, sponsored,demutualization., ... provider of professional,liability to doctors of podiatric medicine, ... the District of Columbia. PICA,insures other healthcare professionals ...
... Increases 13.4% ... Year Earnings Outlook, ORANGE COUNTY, Calif., Oct. 28 ... developer, manufacturer and marketer,of products that simplify, automate and ... 30, 2008 results.,Total revenue of $758.8 million increased 13.4% ...
... in battle against Trichotillomania. , ... Lafayette, CO (PRWEB) October 28, 2008 ... quarter-sized bald spot just above her daughter,s right ear. A few ... Their pediatrician assured Tina that children often do things that seem ...
... for The Hope Honors, Patrick Dempsey, Lauren Conrad, Jordin Sparks, ... DOWNLOADABLE VIDEO, STILLS AND PRESS INFORMATION AVAILABLE AT:, ... on Wednesday, October 29, 2008), NEW YORK, Oct. 28 , ... and wife Jillian Dempsey, celebrity ...
Cached Medicine News:Health News:Elaborate Network Drives When and Where Proteins Are Made 2Health News:Sonic Innovations Announces Results for Third Quarter 2008 2Health News:Sonic Innovations Announces Results for Third Quarter 2008 3Health News:Sonic Innovations Announces Results for Third Quarter 2008 4Health News:Sonic Innovations Announces Results for Third Quarter 2008 5Health News:Sonic Innovations Announces Results for Third Quarter 2008 6Health News:Sonic Innovations Announces Results for Third Quarter 2008 7Health News:Sonic Innovations Announces Results for Third Quarter 2008 8Health News:The PICA Group Will Become Part of ProAssurance 2Health News:The PICA Group Will Become Part of ProAssurance 3Health News:The PICA Group Will Become Part of ProAssurance 4Health News:The PICA Group Will Become Part of ProAssurance 5Health News:The PICA Group Will Become Part of ProAssurance 6Health News:The PICA Group Will Become Part of ProAssurance 7Health News:The PICA Group Will Become Part of ProAssurance 8Health News:Beckman Coulter Announces Third Quarter 2008 Results 2Health News:Beckman Coulter Announces Third Quarter 2008 Results 3Health News:Beckman Coulter Announces Third Quarter 2008 Results 4Health News:Beckman Coulter Announces Third Quarter 2008 Results 5Health News:Beckman Coulter Announces Third Quarter 2008 Results 6Health News:Beckman Coulter Announces Third Quarter 2008 Results 7Health News:Beckman Coulter Announces Third Quarter 2008 Results 8Health News:Beckman Coulter Announces Third Quarter 2008 Results 9Health News:Beckman Coulter Announces Third Quarter 2008 Results 10Health News:Beckman Coulter Announces Third Quarter 2008 Results 11Health News:Beckman Coulter Announces Third Quarter 2008 Results 12Health News:Beckman Coulter Announces Third Quarter 2008 Results 13Health News:Beckman Coulter Announces Third Quarter 2008 Results 14Health News:Beckman Coulter Announces Third Quarter 2008 Results 15Health News:Beckman Coulter Announces Third Quarter 2008 Results 16Health News:Beckman Coulter Announces Third Quarter 2008 Results 17Health News:Beckman Coulter Announces Third Quarter 2008 Results 18Health News:Beckman Coulter Announces Third Quarter 2008 Results 19Health News:Beckman Coulter Announces Third Quarter 2008 Results 20Health News:Beckman Coulter Announces Third Quarter 2008 Results 21
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: